Analyst firms · Barclays · NEM
Barclays NEM price target and rating history
Newmont Corporation (NEM) · Basic Materials
Barclays rates Newmont Corporation (NEM) Overweight with a $133 price target, as of its latest action on May 22, 2026. It has published 3 rating actions on NEM since December 2021, including 1 upgrade and 0 downgrades. Across 6 firms with a NEM price target in the last 12 months, the median target is $131.50. Barclays's $133 is 1% above that.
- Current rating
- Overweight
- Price target
- $133
- Median target, all firms
- $131.50
- Actions on NEM
- 3
Barclays price target on NEM
Every Barclays rating on NEM
- May 22, 2026
- Jul 7, 2023
- Dec 8, 2021
How other firms rate NEM
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| TD Cowen | Buy | $127 | Jul 14, 2026 |
| Barclays | Overweight | $133 | May 22, 2026 |
| National Bank Financial | Sector Perform | $130 | Apr 17, 2026 |
| Bernstein | Outperform | $157 | Feb 27, 2026 |
| BMO Capital Markets | Outperform | $140 | Feb 20, 2026 |
| BNP Paribas Exane | Neutral | $97 | Dec 5, 2025 |
Questions about Barclays and NEM
- What is Barclays's price target for NEM?
- Barclays's latest stated price target for Newmont Corporation (NEM) is $133, from its action on May 22, 2026.
- What is Barclays's rating on NEM?
- Barclays rates NEM Overweight, a bullish rating, as of May 22, 2026.
- When did Barclays last change its view on NEM?
- On May 22, 2026, Barclays starts coverage at Overweight, price target $133.
- How does Barclays's NEM target compare with other analysts?
- Across 6 firms with a NEM price target in the last 12 months, the median target is $131.50. Barclays's $133 is 1% above that.
More NEM rating histories
- National Bank Financial3
- BMO Capital Markets3
- Scotiabank5
- Goldman Sachs4
- UBS5
- CIBC4
- TD Securities3
- Canaccord Genuity4
All Barclays ratingsNEM news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.